Inotek Pharmaceuticals Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Inotek Pharmaceuticals Corp
TickerRCKT
CIK #0001281895
CUSIP77313F106
SectorLife Sciences - Pharmaceutical Preparations
Address131 Hartwell Ave 1St Floor, Suite 105, Lexington, MA 02421
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Inotek Pharmaceuticals Corp 2010-06-23 23.6 M Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001281895] 10-K
[0001281895] 10-Q
[0001281895] 3
[0001281895] 4
[0001281895] 5
[0001281895] 8-K
[0001281895] SC 13D
[0001281895] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Maverick Capital Ltd Rocket Pharmaceuticals Inc [2025-04-14] 0.0
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2024-02-08] 0.09
State Street Corp Rocket Pharmaceuticals Inc [2023-01-31] 5.05
Vanguard Group Inc Rocket Pharmaceuticals Inc [2022-02-10] 5.12
BlackRock Inc Rocket Pharmaceuticals Inc [2022-02-04] 5.2
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2022-02-04] 5.42
Perceptive Advisors LLC Rocket Pharmaceuticals Inc [2021-02-16] 5.6
Price T Rowe Associates Inc /MD/ Rocket Pharmaceuticals Inc [2021-02-16] 5.7
Adage Capital Partners GP LLC Rocket Pharmaceuticals Inc [2019-01-17] 5.35
Boxer Capital LLC Rocket Pharmaceuticals Inc [2018-01-19] 0.0
RTW Investments LP Rocket Pharmaceuticals Inc [2018-01-16] 46.68
Tang Capital Partners LP Rocket Pharmaceuticals Inc [2018-01-16] 8.1
Opaleye Management Inc Inotek Pharmaceuticals Corp [2017-10-06] 11.0
Adage Capital Partners GP LLC Inotek Pharmaceuticals Corp [2017-10-05] 5.55
BML Investment Partners LP Inotek Pharmaceuticals Corp [2017-09-20] 5.5
OrbiMed Advisors LLC Inotek Pharmaceuticals Corp [2017-02-13] 4.68
Great Point Partners LLC Inotek Pharmaceuticals Corp [2017-01-03] 5.07
Citadel Advisors LLC Inotek Pharmaceuticals Corp [2016-08-29] 6.5
Astrazeneca PLC Inotek Pharmaceuticals Corp [2016-02-16] 7.3
RS Investment Management Co LLC Inotek Pharmaceuticals Corp [2016-02-12] 6.0
Rho Ventures IV QP LP Inotek Pharmaceuticals Corp [2016-02-12] 9.9
Franklin Resources Inc Inotek Pharmaceuticals Corp [2016-02-09] 5.8
Prudential Financial Inc Inotek Pharmaceuticals Corp [2016-02-03] 7.3
Jennison Associates LLC Inotek Pharmaceuticals Corp [2016-02-03] 7.3
BlackRock Inc Inotek Pharmaceuticals Corp [2016-01-28] 6.5
Point72 Asset Management LP Inotek Pharmaceuticals Corp [2015-08-24] 2.4
Polygon Management Ltd Inotek Pharmaceuticals Corp [2015-08-03] 6.372
Devon Park BioVentures LP Inotek Pharmaceuticals Corp [2015-03-05] 20.42
Care Capital III LLC Inotek Pharmaceuticals Corp [2015-03-05] 0.6
Form 3/4/5 Filer 2011 - 2026
Rocket Pharmaceuticals Inc
Manhede Joseph
Wong Roderick
Boess Carsten
Dolsten Mikael
Malik Fady Ibraham
Southwell David P
Fong Peter
Militello John
Shah Gaurav
Wilson Martin
Chaudhuri Sarbani
Rizvi Syed Ali-aamir
Stevens Christopher James
Bjork Elisabeth
Schwartz Jonathan David
Pratumsuwan Piratip
Granadillo Pedro P
Makker Gotham
Ondrey Aaron
Patel Kinnari
RTW Investments LP
White Mark Andrew
Yalamanchi Naveen
Woods Keith
Garcia-Parada Carlos
Alam Kamran
Batchelder Brian
Ritter Dale
Machado Patrick
Barberich Timothy J
Howes Paul G
Phillips Gary M
Carroll J Martin
Spivey Richard N
Baumgartner Rudolf A
Devon Park BioVentures LP
Devon Park Associates LLC
Devon Park Associates LP
McVicar William K
Rho Ventures IV-A LP
Rho Ventures IV Holdings LLC
Kantesaria Devang
Vogelbaum Martin
Harel Ittai
Karabelas Argeris N
Peimer Isai
Care Capital II LLC
Care Capital Offshore Investments III LP
Care Capital Investments II LP
Care Capital III LLC
Care Capital Offshore Investments II LP
Care Capital Investments III LP
MedImmune Ventures Inc
Pitango VC Fund IV LP
Pitango Venture Capital Fund IV LP
Pitango GC Capital Holdings Ltd
Pitango Venture Capital Principals Fund IV LP
Rho Capital Partners Verwaltungs GmbH
Rho Management Ventures IV LLC
Rho Ventures IV QP LP
Rho Ventures IV GmbH & Co Beteiligungs KG
Ruch Joshua
Kairouz Habib
Rho Ventures IV LP
Leschly Mark
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Wilson Martin
Common Stock
2026-02-18 Sell 1,376 $3.34 4,596
Shah Gaurav
Common Stock
2026-02-18 Sell 5,990 $3.34 20,007
Militello John
Common Stock
2026-02-18 Sell 1,157 $3.34 3,864
Wilson Martin
Common Stock
2026-02-13 Sell 12,253 $3.31 40,557
Militello John
Common Stock
2026-02-13 Sell 3,726 $3.31 12,333
Shah Gaurav
Common Stock
2026-02-13 Sell 12,279 $3.31 40,643
Chaudhuri Sarbani
Common Stock
2026-02-11 Grant 125,924 $0.00
Militello John
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 45,018 $0.00
Stevens Christopher James
Common Stock
2026-02-11 Grant 61,963 $0.00
Militello John
Common Stock
2026-02-11 Grant 29,982 $0.00
Wilson Martin
Common Stock
2026-02-11 Grant 311,813 $0.00
Rizvi Syed Ali-aamir
Stock Option (right to buy) · derivative
2026-02-11 Grant 93,037 $0.00
Stevens Christopher James
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 93,037 $0.00
Shah Gaurav
Common Stock
2026-02-11 Grant 286,028 $0.00
Chaudhuri Sarbani
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 189,076 $0.00
Shah Gaurav
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 870,648 $0.00
Rizvi Syed Ali-aamir
Common Stock
2026-02-11 Grant 61,963 $0.00
Wilson Martin
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 468,187 $0.00
Bjork Elisabeth
Common Stock
2026-01-02 Buy 10,000 $3.44 34,400
Schwartz Jonathan David
Common Stock
2025-11-18 Sell 2,545 $2.98 7,584
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 199 97,647,534
2025-12-31 186 91,224,511
2025-09-30 174 99,529,803
2025-06-30 196 95,962,215
2025-03-31 241 105,231,365
2024-12-31 227 106,686,599
2024-09-30 195 90,206,662
2024-06-30 183 89,224,724
2024-03-31 193 91,804,591
2023-12-31 199 88,367,849
2023-09-30 177 87,096,313
2023-06-30 165 75,563,595
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 224,927 224,927
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 5,274 91,568
Assenagon Asset Management SA [2026-06-30] SOLE 84,815 84,815
Ballentine Partners LLC [2026-06-30] OTR 0 70,405
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 17,653
Merit Financial Group LLC [2026-06-30] OTR 0 14,498
Grimes & Company Inc [2026-06-30] SOLE 5,188 12,001
Merit Financial Group LLC [2026-06-30] SOLE 29 4,862
Farther Finance Advisors LLC [2026-06-30] SOLE 0 2,655
IFP Advisors LLC [2026-06-30] SOLE 1,818 1,818
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 1,300
Gamma Investing LLC [2026-06-30] DFND 1,213 1,213
True Wealth Design LLC [2026-06-30] SOLE 0 873
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 568
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 114 114
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com